← Back to Clinical Trials
Recruiting NCT07902466

NCT07902466 Short-Term Effects of Manual Therapy Prior to Neuromotor Therapy in Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07902466
Status Recruiting
Phase —
Sponsor LIFE - Research and Care Institute - Santa Lucia IRCCS
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-10-15
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 12 Months
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
Manual Therapy (T1 & T3)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-10-15 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This pilot study aims to evaluate the immediate, short-term biomechanical and neuromuscular effects of lower limb manual therapy applied as a preparatory phase prior to functional neuromotor rehabilitation in children with spastic cerebral palsy (hemiplegic and diplegic forms). Using a prospective self-controlled design, 20 children will be assessed under four experimental conditions (baseline, post-manual therapy, post-functional therapy, and post-combined manual + functional therapy) to determine if manual techniques enhance gait parameters and motor execution.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of spastic Cerebral Palsy with lower limb involvement (hemiplegia or diplegia). * Age between 12 months and 10 years. * Gross Motor Function Classification System (GMFCS) level I, II, III, or IV. * Modified Ashworth Scale (MAS) score ≤ 3 in the lower limbs. Exclusion Criteria: * Botulinum toxin injection in the lower limbs within the past 6 months. * Prior functional orthopedic or neurosurgical procedures on the lower limbs. * Concurrent participation in other experimental clinical studies involving the lower limbs. * Cognitive impairment preventing comprehension of required motor tasks.

Contact & Investigator

Central Contact

Chiara Fantini, PT

✉ c.fantini@hsantalucia.it

📞 +39 0651501490

Frequently Asked Questions

Who can join the NCT07902466 clinical trial?

This trial is open to participants of all sexes, aged 12 Months or older, up to 10 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07902466 currently recruiting?

Yes, NCT07902466 is actively recruiting participants. Contact the research team at c.fantini@hsantalucia.it for enrollment information.

Where is the NCT07902466 trial being conducted?

This trial is being conducted at Roma, Italy.

Who is sponsoring the NCT07902466 clinical trial?

NCT07902466 is sponsored by LIFE - Research and Care Institute - Santa Lucia IRCCS. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology